CMS certification 290001
Renown Regional Medical Center
1155 Mill Street, Reno, NV 89502
Renown Regional Medical Center has a CMS overall rating of 3 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 1. Emergency patients spend a median of 2 h 56 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 849 completed surveys, 24% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NV | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 371 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 56 min | 2 h 25 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 26 visits sampled | 5 h 16 min | 4 h 3 min | 4 h 17 min |
| Left before being seen Lower is better · 87,646 patients | 2% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 211 patients | 72% | 71% | 65% |
How Renown Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Renown Regional Medical CenterThis hospital | 3/5 | 69% | 2 h 56 min | 4 better 1 worse |
| VA Sierra Nevada Healthcare SystemSame city | 5/5 | 75% | — | 2 better 1 worse |
| Saint Mary's Regional Medical CenterSame city | 4/5 | 71% | 2 h 20 min | 1 worse |
| Renown South Meadows Medical CenterSame city | 3/5 | 76% | 3 h 1 min | 1 better 1 worse |
| Northern Nevada Medical CenterSame county · Sparks | 3/5 | 73% | 2 h 25 min | No different |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Reno.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,021 cases | Too few cases | 3.4% | 3.9% |
| Heart attack 592 cases | Too few cases | 11% | 11.9% |
| Heart failure 734 cases | Too few cases | 12.9% | 11.1% |
| Pneumonia 585 cases | Too few cases | 15.4% | 15.2% |
| Stroke 683 cases | Too few cases | 11% | 11.9% |
| COPD 225 cases | Too few cases | 8.6% | 8.6% |
| Heart bypass surgery (CABG) 123 cases | Too few cases | 2.3% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.04 likely 0.81 – 1.27 | 1 |
| Deaths after a serious but treatable surgical complication 302 cases | Worse | 231.33 per 1,000 likely 200.05 per 1,000 – 262.61 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 11,907 cases | Better | 0.14 per 1,000 likely 0 per 1,000 – 0.56 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 14,463 cases | No different | 0.27 per 1,000 likely 0.11 per 1,000 – 0.44 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 14,984 cases | No different | 0.33 per 1,000 likely 0.16 per 1,000 – 0.5 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 4,125 cases | No different | 3.24 per 1,000 likely 2.11 per 1,000 – 4.36 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,605 cases | No different | 2.62 per 1,000 likely 1.22 per 1,000 – 4.02 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,560 cases | No different | 11.78 per 1,000 likely 7 per 1,000 – 16.56 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,503 cases | No different | 4.71 per 1,000 likely 3.29 per 1,000 – 6.12 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,551 cases | No different | 5.2 per 1,000 likely 2.2 per 1,000 – 8.2 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,024 cases | No different | 1.53 per 1,000 likely 0.22 per 1,000 – 2.83 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,106 cases | No different | 1.14 per 1,000 likely 0.36 per 1,000 – 1.92 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.21 likely 0.07 – 0.5 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.44 likely 0.24 – 0.73 | 1 |
| Surgical site infections after colon surgery | Better | 0.34 likely 0.11 – 0.83 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.73 likely 0.04 – 3.58 | 1 |
| MRSA bloodstream infections | No different | 0.53 likely 0.23 – 1.05 | 1 |
| C. diff intestinal infections | Better | 0.64 likely 0.48 – 0.83 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 668 cases | Too few cases | 12.9% | 14.4% |
| Readmitted after heart failure 1,041 cases | Too few cases | 22.2% | 21.3% |
| Readmitted after pneumonia 776 cases | Too few cases | 18.3% | 17.3% |
| Readmitted after COPD 354 cases | Too few cases | 20.1% | 20% |
| Readmitted after heart bypass surgery 107 cases | Too few cases | 10% | 11% |
| Days back in hospital after a heart attack 643 cases | Too few cases | -11.3 days per 100 | — |
| Days back in hospital after heart failure 850 cases | Too few cases | 1.6 days per 100 | — |
| Days back in hospital after pneumonia 631 cases | Too few cases | -8.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 50 cases | No different | 13.3 per 1,000 likely 9.8 per 1,000 – 18.1 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 547 cases | Better | 7.9 per 100 likely 6.3 per 100 – 9.9 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 547 cases | No different | 4.8 per 100 likely 3.6 per 100 – 6.5 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 948 cases | No different | 1.1 likely 0.8 – 1.3 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
528 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 17 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Hospitalist | 80 |
| Pharmacist | 55 |
| Emergency Medicine | 45 |
| Anesthesiology | 35 |
| Internal Medicine | 35 |
| Dietitian, Registered | 25 |
| Diagnostic Radiology | 23 |
| Family | 23 |
| Critical Care Medicine | 19 |
| Acute Care | 16 |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist | 11 |
| Registered Nurse | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $315,589
- 2020 $292,228
- 2021 $895,167
- 2022 $505,100
- 2023 $1M
- 2024 $1.6M
- 2025 $3M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $24,225 | 22 |
| Medical devices and supplies on long-term loan | $1,506 | 4 |
| Debt forgiveness | $414 | 4 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Pfizer INC. | $946,659 | 63 |
| Merck Sharp & Dohme LLC | $842,170 | 8 |
| Histosonics, INC. | $209,034 | 2 |
| Amgen Inc. | $164,798 | 3 |
| E.R. Squibb & Sons, L.L.C. | $142,726 | 3 |
| Genzyme Corporation | $110,496 | 22 |
| Genentech, Inc. | $109,866 | 50 |
| Novartis Pharmaceuticals Corporation | $106,017 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| AN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITOR PLUS LETROZOLE IN PARTICIPA… PFIZER INC. | $684,314 |
| A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not… Merck Sharp & Dohme LLC | $285,450 |
| A Randomized, Open label, Phase 3 Study of MK-2870 in Combination with Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatmen… Merck Sharp & Dohme LLC | $269,709 |
| A PHASE 1B2 OPENLABEL STUDY OF DISITAMAB VEDOTIN IN COMBINATION WITH OTHER ANTICANCER THERAPIES IN SOLID TUMORS PFIZER INC. | $131,741 |
| A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy as … E.R. Squibb & Sons, L.L.C. | $114,923 |
| A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positiv… Merck Sharp & Dohme LLC | $113,738 |
| A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cance… Novartis Pharmaceuticals Corporation | $87,017 |
| A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan sac-TMT, MK-2870 as a Monotherapy and in Combination… Merck Sharp & Dohme LLC | $86,640 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Renown Regional Medical Center
Is Renown Regional Medical Center a good hospital?
Renown Regional Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Renown Regional Medical Center?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 849 completed HCAHPS surveys.
How long is the wait in the Renown Regional Medical Center emergency room?
Emergency patients spend a median of 2 h 56 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Renown Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $3M in payments to Renown Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.